According to a forecast published by Fact.MR, the global platelet-rich plasma market will be worth $391 million by 2022. This projected growth is being fueled by many factors including the growing body of evidence surrounding the efficacy of platelet-rich plasma therapies and positive patient outcomes. There are a growing number of healthcare applications for PRP…
Read MoreIt is difficult to standardize PRP. This lack of standardization and consistency is prevalent throughout the literature and has made it to difficult to compare results between products and results. To determine the efficacy of PRP from system to system and patient to patient, the components of PRP and the delivery system to the target tissue site should…
Read More